NEW YORK (GenomeWeb News) – Arcxis Biotechnologies said today that it will collaborate with Roche Molecular Systems, a business area of Roche Diagnostics, on sample-preparation technology for molecular diagnostics.
 
Under the collaboration, Arcxis will use its proprietary total RNA and genomic DNA isolation and concentration technology with PCR and RT-PCR-based diagnostic tests. The company expects that its methods for preparing blood and tissue will produce “significant performance benefits” for PCR-based tests.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.